Related Experiment Video
Updated: Jul 28, 2025

Endoscopic Cholesteatoma Surgery
Published on: January 19, 2022
Time Analysis of Recidivism in Acquired Cholesteatoma Using the Kaplan-Meier Method
Takara Nakazawa1, Yutaka Yamamoto, Kazuki Kanno
1Department of Otorhinolaryngology, The Jikei University School of Medicine, Tokyo, Japan.
Objective:
To analyze the time trends of recidivism of acquired cholesteatoma using the Kaplan-Meier method.
Study Design:
We conducted a retrospective, observational study of 256 patients having their first cholesteatoma surgery. The cumulative recidivism-free rate was calculated using Kaplan-Meier survival analysis related to the follow-up period, pathophysiology, the extent of the disease, and recidivism pathologies.
Results:
Pars flacida cholesteatoma with tympanic cavity progression had a high likelihood of recurrence disease. Pars tensa cholesteatoma led to more recurrence of the disease than the residual disease. In both pars flacida and pars tensa cholesteatoma, the incidence of disease recurrence increased even 3 years after surgery. On the contrary, the incidence of residual disease peaked within 3 years after surgery, and thereafter, the incidence of residual disease tended to be small. In particular, pars flacida cholesteatoma extending into the mastoid cavity or tympanic cavity tended to recur up to 5 years postoperatively.
Conclusions:
We calculated the cumulative recidivism-free rates of 256 patients with cholesteatoma using Kaplan-Meier survival analysis. These results can lead to better estimates of the length of the follow-up period.
Level Of Evidence:
Level IV evidence from case-control studies.
More Related Videos
Related Concept Videos
Kaplan-Meier Approach
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Assumptions of Survival Analysis

